Internal Medicine · Garden City, NY
NPI
1023342748
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Stewart Ave Ste 201
Garden City, NY, 11530
Phone (516) 227-3377
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
2,053 services
Medicare patients, 2024
430
Average age 73
Drug cost, 2024
$830K
1,174 prescriptions
Company payments, 2025
$2,341
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lotika Singh was code 17003 (destruction skin lesion), 513 times for 67 patients. In total Lotika Singh billed 2,053 services in 40 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 513 | 67 | $5.79 | $2,969 |
| 99213 Office E&M - Established | Office | 506 | 302 | $73.07 | $37K |
| 17110 Destruction Skin Lesion | Office | 182 | 118 | $96.00 | $17K |
| 17000 Destruction Skin Lesion | Office | 142 | 94 | $45.46 | $6,455 |
| 99214 Office E&M - Established | Office | 111 | 69 | $104.77 | $12K |
| 99212 Office E&M - Established | Office | 111 | 79 | $47.60 | $5,283 |
| 11102 Skin Biopsy | Office | 79 | 70 | $74.09 | $5,853 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 73 | 35 | $0.71 | $52.13 |
| 99203 Office E&M - New | Office | 68 | 68 | $90.52 | $6,155 |
| 17004 Destruction Skin Lesion | Office | 53 | 30 | $129.62 | $6,870 |
| 10040 Removal or Shaving of Skin Growth | Office | 41 | 34 | $97.50 | $3,998 |
| 11901 Skin | Office | 36 | 14 | $52.32 | $1,884 |
| 11900 Skin | Office | 29 | 24 | $40.47 | $1,174 |
| 17111 Destruction Skin Lesion | Office | 18 | 11 | $124.02 | $2,232 |
By year: 2022 $99K for 1,532 services; 2023 $120K for 2,148 services; 2024 $118K for 2,053 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lotika Singh prescribed most often to Medicare patients was Minoxidil, with 122 prescriptions and refills. In total Lotika Singh wrote 1,174 Medicare prescriptions that cost $830K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 122 | 333 | 50 | $950 |
| Triamcinolone Acetonide Generic | 97 | 99 | 75 | $889 |
| Clobetasol Propionate Generic | 69 | 69 | 47 | $2,856 |
| Ketoconazole Generic | 67 | 80 | 42 | $883 |
| Ciclopirox Generic | 67 | 77 | 25 | $2,623 |
| Ammonium Lactate Generic | 61 | 65 | 35 | $1,147 |
| Tacrolimus Generic | 57 | 69 | 34 | $14K |
| Finasteride Generic | 53 | 137 | 21 | $650 |
| Spironolactone Generic | 52 | 116 | 16 | $284 |
| Hydrocortisone Generic | 38 | 38 | 36 | $212 |
| Clindamycin Phosphate Generic | 32 | 37 | 13 | $1,109 |
| Mupirocin Generic | 28 | 29 | 24 | $139 |
| Calcipotriene Generic | 25 | 27 | Under 11 | $5,138 |
| Nystatin Generic | 25 | 31 | Under 11 | $385 |
| Dutasteride Generic | 25 | 63 | Under 11 | $488 |
Brand drugs: 181 claims; generic drugs: 993 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lotika Singh $2,341 ($2,341 in general payments such as food, travel and fees) from 19 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $363.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $363 |
| Botanix SB Inc | 19 | $312 |
| Janssen Biotech, Inc. JNJ | 8 | $217 |
| Galderma Laboratories, L.P. GALD.SW | 15 | $199 |
| Abbvie Inc. ABBV | 10 | $161 |
| Incyte Corporation INCY | 7 | $153 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $124 |
| LEO Pharma Inc. | 5 | $117 |
| Pfizer Inc. PFE | 5 | $116 |
| Genzyme Corporation SNY | 4 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.